Next Article in Journal
A Translational Paradigm to Study the Effects of Uncontrollable Stress in Humans
Next Article in Special Issue
Interleukin-36 Cytokine/Receptor Signaling: A New Target for Tissue Fibrosis
Previous Article in Journal
Garlic Substrate Induces Cucumber Growth Development and Decreases Fusarium Wilt through Regulation of Soil Microbial Community Structure and Diversity in Replanted Disturbed Soil

Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies

Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, 40138 Bologna, Italy
Centre for Applied Biomedical Research (CRBA), Bologna University Hospital Authority St. Orsola-Malpighi Polyclinic, 40138 Bologna, Italy
Department of Oncology, Policlinico S. Orsola-Malpighi, University of Bologna, 40138 Bologna, Italy
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2020, 21(17), 6009;
Received: 11 July 2020 / Revised: 4 August 2020 / Accepted: 18 August 2020 / Published: 20 August 2020
(This article belongs to the Special Issue Regulation of Inflammatory Reactions in Health and Disease)
IL-1 belongs to a family of 11 members and is one of the seven receptor-agonists with pro-inflammatory activity. Beyond its biological role as a regulator of the innate immune response, IL-1 is involved in stress and chronic inflammation, therefore it is responsible for several pathological conditions. In particular, IL-1 is known to exert a critical function in malignancies, influencing the tumor microenvironment and promoting cancer initiation and progression. Thus, it orchestrates immunosuppression recruiting pro-tumor immune cells of myeloid origin. Furthermore, new recent findings showed that this cytokine can be directly produced by tumor cells in a positive feedback loop and contributes to the failure of targeted therapy. Activation of anti-apoptotic signaling pathways and senescence are some of the mechanisms recently proposed, but the role of IL-1 in tumor cells refractory to standard therapies needs to be further investigated. View Full-Text
Keywords: IL-1; cancer; resistance IL-1; cancer; resistance
Show Figures

Figure 1

MDPI and ACS Style

Gelfo, V.; Romaniello, D.; Mazzeschi, M.; Sgarzi, M.; Grilli, G.; Morselli, A.; Manzan, B.; Rihawi, K.; Lauriola, M. Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies. Int. J. Mol. Sci. 2020, 21, 6009.

AMA Style

Gelfo V, Romaniello D, Mazzeschi M, Sgarzi M, Grilli G, Morselli A, Manzan B, Rihawi K, Lauriola M. Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies. International Journal of Molecular Sciences. 2020; 21(17):6009.

Chicago/Turabian Style

Gelfo, Valerio, Donatella Romaniello, Martina Mazzeschi, Michela Sgarzi, Giada Grilli, Alessandra Morselli, Beatrice Manzan, Karim Rihawi, and Mattia Lauriola. 2020. "Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies" International Journal of Molecular Sciences 21, no. 17: 6009.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop